(Q73428325)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172948%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Optimizing patient selection for prostate monotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172948%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

A K Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172948%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

D Schultz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172948%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A A Renshaw

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172948%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J P Richie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172948%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A V D'Amico

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172948%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172948%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172948%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172948%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172948%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

673-677

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172948%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901421-8

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901421-8

7 January 2021

Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901421-8

7 January 2021

Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901421-8

7 January 2021

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901421-8

7 January 2021

Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901421-8

7 January 2021

Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901421-8

7 January 2021

The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901421-8

7 January 2021

The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901421-8

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901421-8

7 January 2021

Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901421-8

7 January 2021

Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901421-8

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901421-8

7 January 2021

10.1016/S0360-3016(00)01421-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11172948%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference